Genetics is just one trend of reductionism that pervades modern biomedical research and practice, preceded earlier by germ theory and is currently followed by the nanotechnology. What all these trends share in common is their positivist background with a tireless search for the materialized occult. Modern medicine, after all, has not discarded the magic fervor for hocus-pocus that will turn all ills into health.
2 While many traditional cultures believe in extra-somatic powers as causes of illnesses, modern biomedical knowledge is built on the assumption of searching for materialized intra-somatic powers that constitute the magic hex causing the illness from within. 3 These were initially germs and, then, genes.
Genetic research, therefore, is just one of many trends in the paradigm of biomedical practice and research under the umbrella of positivism and empiricism.
Biomedical knowledge is being constructed through empirical research based on a positivist approach. However, it is well recognized that this approach addresses only a fractioned part of the health and illness phenomena, has many flaws and false findings, and has a wide gap between research results and clinical practice. [4] [5] [6] Despite that, the problem is thought to be merely about accumulating more knowledge, developing high-tech interventions and the application of harder measures for mitigation against such flaws and failures without realizing the vicious cycle that we get entangled within. Experimental design as the gold standard for research in the biomedical model is built to enhance the existing assumptions and beliefs of this paradigm. 7 Therefore, it is unable to see, let apart identify possible alternatives.
In addition, the currently knowledge-accumulating,
intervention-focused research model may not necessarily result in improved health care systems or practices. Woolf and Johnson have studied the comparative efficacy of huge investments in technological innovations versus improving health system delivery.
8
They have concluded that technological innovations may cost more lives than it saves as they consume resources that could be used to deliver, more efficaciously, older agents to all patients. This is consistent with a view of medicine as a socio-technical system rather than being merely a technical discipline as mostly presented and practiced, implicitly or explicitly, in biomedical research.
On the other hand, the commonly portrayed view of philanthropic intentions of research practice may not reflect actual drivers of the enterprise. Kramer had identified 5 levels of goals for doing medical research: to improve CV, to derive satisfaction, to increase knowledge, to change behavior and to improve health. Probably, the first step outside this vicious cycle is to recognize and acknowledge that biomedical research and practice, as they exist, are neither optimal nor the best way to improve health of populations. Moreover, future of modern science lies in liberating scientists from the tyranny of empiricism toward a more balanced view. 13 This requires exploring and exploiting different concepts of scientific knowledge, health and health systems. The aim here is not to halt research but re-direct it hoping that it will move forward in a socially, morally and scientifically sound way. 14 On the other hand, the misalignment of priorities could be overcome by reconsidering the final goals of scientific research and practice. What is needed is a paradigm that adopts a view of medical knowledge and practice as a socio-technical discipline, and espouses an outcome-based research endeavor that is focused primarily to yield better population health, not longer CVs or higher market profits.
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